Reconsolidation of a Cocaine-associated Stimulus Requires Amygdalar Protein Kinase A
Overview
Affiliations
Drug addiction is a chronic disorder associated with recurrent craving and relapse often precipitated by the presence of drug-associated stimuli. Pharmacological and behavioral treatments that disrupt drug-associated stimulus memories could be beneficial in the treatment of addictive disorders. Memory restabilization (or reconsolidation) following retrieval of drug-paired stimuli depends upon the amygdala. Here we assessed whether amygdalar PKA is required for the reconsolidation of an appetitive, cocaine-paired stimulus. Rats were trained to lever press for intravenous cocaine infusions paired with a light/tone conditioned stimulus. After 12 d of acquisition, rats either underwent lever extinction (8-12 d) followed by light/tone reactivation and subsequent cue-induced and cocaine-induced (15 mg/kg, i.p.) reinstatement testing or were subsequently tested to assess the ability of the light/tone stimulus to serve as a conditioned reinforcer in the acquisition of a new instrumental response (nose poking). Bilateral intra-amygdalar infusions of the PKA inhibitor Rp-cAMPS (18 microg per side) given immediately following light/tone stimulus reactivation decreased subsequent cue-induced reinstatement and responding with a conditioned reinforcer, while having no effect on cocaine-induced reinstatement. Intra-amygdalar infusions of Rp-cAMPS made 3 h following reactivation or immediately following no stimulus reactivation had no effect on subsequent cue-induced reinstatement. These data show that memory reconsolidation for a cocaine-paired stimulus is retrieval dependent and time limited and critically depends upon amygdalar PKA.
Huang S, Liu X, Li Z, Si Y, Yang L, Deng J Neurosci Bull. 2024; 41(2):289-304.
PMID: 39264570 PMC: 11794923. DOI: 10.1007/s12264-024-01294-z.
Ritchie J, Qi S, Soto D, Swatzell S, Grenz H, Pruitt A Neuropsychopharmacology. 2024; 49(13):2077-2086.
PMID: 38802479 PMC: 11480471. DOI: 10.1038/s41386-024-01892-5.
Ritchie J, Qi S, Soto D, Swatzell S, Grenz H, Pruitt A bioRxiv. 2024; .
PMID: 38405858 PMC: 10888894. DOI: 10.1101/2024.02.10.579725.
Drug memory reconsolidation: from molecular mechanisms to the clinical context.
Milton A Transl Psychiatry. 2023; 13(1):370.
PMID: 38040677 PMC: 10692359. DOI: 10.1038/s41398-023-02666-1.
Charpentier A, Olekanma D, Valade C, Reeves C, Cho B, Arguello A Sci Rep. 2023; 13(1):13936.
PMID: 37626103 PMC: 10457301. DOI: 10.1038/s41598-023-39949-y.